GMP LR3 IGF-I/IGF-1 Protein, Human (83a.a, E51R) Based on 1 Customer Validation The LR3 IGF-I/IGF-1 protein is similar to insulin and has potent growth-promoting activity that exceeds the efficacy of insulin
Its safety profile has specifically been demonstrated in pediatric populations, where it has been FDA-approved and used without significant adverse outcomes [12, 13]
8 weeks 2 vials 8 full weekly maintenance doses
Keep researching More about Sermorelin Compare next Related Growth & Performance Real-world Sermorelin videos from creators Authentic TikTok and Instagram clips where creators talk about Sermorelin, each paired with a clinical fact-check from the FormBlends medical team
This comparison is mechanistically distinct from IGF-1 LR3 vs MGF (ID 77399, which covers local satellite cell biology versus systemic signalling), the CJC-1295 muscle post (ID 77296, which covers GH axis and protein synthesis in depth), and the GH secretagogue hub (ID 77059) this comparison focuses specifically on the mechanistic differences in how each compound reaches and activates skeletal muscle IGF-1R, the downstream signalling divergences, and what this means for muscle research protocol design
On the contrary, an excess is starting to be associated with: the proliferation and onset of cancer, hepatic-renal damage, neurodegenerative diseases, as well as heart and cardiovascular diseases
